COMPuter-assisted Self-training to Improve EXecutive Function
NCT ID: NCT04229056
Last Updated: 2025-02-20
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
NA
307 participants
INTERVENTIONAL
2020-06-01
2026-06-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
CBCR for Executive Functions in Patients With ABI in the Chronic Phase
NCT03558308
Does Computerized Cognitive Training Improve Executive Functioning in the Older Adult?
NCT03170492
Exploring the Long-term Effects of Cognitive Exercise on Cognition After Stroke
NCT01948089
Pilot Study to Determine if Working Memory Training Aids Cognitive Functioning in Patients With Parkinson's Disease
NCT01647698
Computer-based Cognitive Rehabilitation Program for Healthy Older Adults, Older People With Mild Cognitive Impairment and Mild Dementia
NCT03430401
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Specific computer-based cognitive rehabilitation
154 patients will be allocated to specific computer-based cognitive rehabilitation. This group will train with 10 exercises from the cognitive rehabilitation software 'Scientific Brain training PRO'. These 10 exercises are designed to train various executive functions.
Computer-based cognitive rehabilitation (CBCR)
CBCR are software-programmes for computers which are clinically developed for rehabilitation of various cognitive functions.
General computer-based cognitive stimulation
154 patients will be allocated to general computer-based cognitive stimulation. This group will train with 10 generally mentally stimulating games on a website specifically designed for this trial. These 10 games are chosen because they are believed to have a low load on executive functions but stimulate over-all concentration and visuoperceptual abilities.
General computer-based cognitive stimulation
For this trial we have developed a webpage for general cognitive stimulation, which is designed to provide general computer-based cognitive stimulation.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Computer-based cognitive rehabilitation (CBCR)
CBCR are software-programmes for computers which are clinically developed for rehabilitation of various cognitive functions.
General computer-based cognitive stimulation
For this trial we have developed a webpage for general cognitive stimulation, which is designed to provide general computer-based cognitive stimulation.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Aged 18 years or older.
* Impaired working memory measured with CABPad working memory test, cut off for inclusion: 5 symbols or less backwards
* Computer and internet access at home.
* Providing informed consent.
* Inclusion within 6 months post-stroke
* Stroke confirmed by clinical findings and imaging, both AIS and ICH is allowed.
* Initial stroke severity \>/= NIHSS 3.
• Inclusion within 6 months post ictus.
* Clinical diagnosis of PD.
* Anti-parkinsonian medical treatment (dopaminergic or other).
Exclusion Criteria
* Other neurological or psychiatric disease which is expected to influence the patient's ability to participate in the trial according to the investigator
* Not able to participate according to investigator
* Patients with massive anosognosia for executive dysfunction or patients with no subjective feeling of executive dysfunction (Patient sustains total denial of executive symptoms over time)
* Patients with severe aphasia, in which it is unclear whether the patient's performance on a neuropsychological test-battery is due to aphasia and not executive dysfunction.
• Diagnosis of PD Dementia according to the MDS PD Dementia criteria
18 Years
100 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Rigshospitalet, Denmark
OTHER
University of Glasgow
OTHER
University of Basel
OTHER
Copenhagen Trial Unit, Center for Clinical Intervention Research
OTHER
Hjernesagen
UNKNOWN
Göteborg University
OTHER
Aalborg University Hospital
OTHER
Neurorehabilitering - Kbh, City of Copenhagen
OTHER
Bispebjerg Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Hanne Christensen
Professor
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Hanne Christensen, Professor
Role: PRINCIPAL_INVESTIGATOR
Bispebjerg Hospital
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Bispebjerg Hospital
Copenhagen, , Denmark
Rigshospitalet
Copenhagen, , Denmark
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Hanne Christensen, MD, Professor
Role: primary
Jesper Kjaergaard, MD
Role: primary
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
H-19039236
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.